These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
259 related items for PubMed ID: 18030230
21. Osteopenia in children who have undergone posterior fossa or craniospinal irradiation for brain tumors. Krishnamoorthy P, Freeman C, Bernstein ML, Lawrence S, Rodd C. Arch Pediatr Adolesc Med; 2004 May; 158(5):491-6. PubMed ID: 15123484 [Abstract] [Full Text] [Related]
22. Primary biliary cirrhosis is not an additional risk factor for bone loss in women receiving regular calcium and vitamin D supplementation: a controlled longitudinal study. Benetti A, Crosignani A, Varenna M, Giussani CS, Allocca M, Zuin M, Podda M, Battezzati PM. J Clin Gastroenterol; 2008 Mar; 42(3):306-11. PubMed ID: 18223492 [Abstract] [Full Text] [Related]
23. Attempted randomized controlled trial of pamidronate versus calcium and calcitriol supplements for management of steroid-induced osteoporosis in children and adolescents. Brown JJ, Zacharin MR. J Paediatr Child Health; 2005 Nov; 41(11):580-2. PubMed ID: 16398842 [Abstract] [Full Text] [Related]
24. Patterns of bone mineral acquisition in children with epidermolysis bullosa: a longitudinal study. Fu T, Lingala B, Kent K, Bachrach LK, Bruckner AL. Br J Dermatol; 2011 Nov; 165(5):1081-6. PubMed ID: 21729034 [Abstract] [Full Text] [Related]
25. Alendronate treatment in children with osteogenesis imperfecta. Akcay T, Turan S, Guran T, Bereket A. Indian Pediatr; 2008 Feb; 45(2):105-9. PubMed ID: 18310788 [Abstract] [Full Text] [Related]
26. Efficacy and harms of nasal calcitonin in improving bone density in young patients with inflammatory bowel disease: a randomized, placebo-controlled, double-blind trial. Pappa HM, Saslowsky TM, Filip-Dhima R, DiFabio D, Hassani Lahsinoui H, Akkad A, Grand RJ, Gordon CM. Am J Gastroenterol; 2011 Aug; 106(8):1527-43. PubMed ID: 21519359 [Abstract] [Full Text] [Related]
27. Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studies. Pastores GM, Elstein D, Hrebícek M, Zimran A. Clin Ther; 2007 Aug; 29(8):1645-54. PubMed ID: 17919546 [Abstract] [Full Text] [Related]
28. Efficacy and tolerability of calcium, vitamin D and a plant-based omega-3 oil for osteopenia: a pilot RCT. Vanlint SJ, Ried K. Maturitas; 2012 Jan; 71(1):44-8. PubMed ID: 22078660 [Abstract] [Full Text] [Related]
29. Effect of pamidronate on bone loss after kidney transplantation: a randomized trial. Walsh SB, Altmann P, Pattison J, Wilkie M, Yaqoob MM, Dudley C, Cockwell P, Sweny P, Banks LM, Hall-Craggs M, Noonan K, Andrews C, Cunningham J. Am J Kidney Dis; 2009 May; 53(5):856-65. PubMed ID: 19393473 [Abstract] [Full Text] [Related]
30. Intravenous pamidronate in combination with calcium and vitamin D: highly effective in the treatment of low bone mineral density in inflammatory bowel disease. Stokkers PC, Deley M, Van Der Spek M, Verberne HJ, Van Deventer SJ, Hommes DW. Scand J Gastroenterol; 2006 Feb; 41(2):200-4. PubMed ID: 16484125 [Abstract] [Full Text] [Related]
31. Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments. Giusti A, Barone A, Pioli G, Girasole G, Siccardi V, Palummeri E, Bianchi G. Nephrol Dial Transplant; 2009 May; 24(5):1472-7. PubMed ID: 19075192 [Abstract] [Full Text] [Related]
32. Impaired bone health in inflammatory bowel disease: a case-control study in 80 pediatric patients. Laakso S, Valta H, Verkasalo M, Toiviainen-Salo S, Viljakainen H, Mäkitie O. Calcif Tissue Int; 2012 Aug; 91(2):121-30. PubMed ID: 22729560 [Abstract] [Full Text] [Related]
33. Lifestyle factors and duration of androgen deprivation affect bone mineral density of patients with prostate cancer during first year of therapy. Ryan CW, Huo D, Stallings JW, Davis RL, Beer TM, McWhorter LT. Urology; 2007 Jul; 70(1):122-6. PubMed ID: 17656221 [Abstract] [Full Text] [Related]
34. Effects of nutritional supplementation on bone mineral status of children with rheumatic diseases receiving corticosteroid therapy. Warady BD, Lindsley CB, Robinson FG, Lukert BP. J Rheumatol; 1994 Mar; 21(3):530-5. PubMed ID: 8006898 [Abstract] [Full Text] [Related]
35. Impact of parathyroid status and Ca and vitamin-D supplementation on bone mass and muscle-bone relationships in 208 Belarussian children after thyroidectomy because of thyroid carcinoma. Schneider P, Biko J, Reiners C, Demidchik YE, Drozd VM, Capozza RF, Cointry GR, Ferretti JL. Exp Clin Endocrinol Diabetes; 2004 Sep; 112(8):444-50. PubMed ID: 15372365 [Abstract] [Full Text] [Related]
36. Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment. Land C, Rauch F, Travers R, Glorieux FH. Bone; 2007 Mar; 40(3):638-44. PubMed ID: 17127117 [Abstract] [Full Text] [Related]
37. Bone mineral density in children with celiac disease. Effect of a Gluten-free diet. Tau C, Mautalen C, De Rosa S, Roca A, Valenzuela X. Eur J Clin Nutr; 2006 Mar; 60(3):358-63. PubMed ID: 16319837 [Abstract] [Full Text] [Related]
38. Reduced spinal bone mineral density in adolescents of an Ultra-Orthodox Jewish community in Brooklyn. Taha W, Chin D, Silverberg AI, Lashiker L, Khateeb N, Anhalt H. Pediatrics; 2001 May; 107(5):E79. PubMed ID: 11331729 [Abstract] [Full Text] [Related]
39. Evolution of bone mineral density after percutaneous kyphoplasty in fresh osteoporotic vertebral body fractures and adjacent vertebrae along with sagittal spine alignment. Korovessis P, Zacharatos S, Repantis T, Michael A, Karachalios D. J Spinal Disord Tech; 2008 Jun; 21(4):293-8. PubMed ID: 18525491 [Abstract] [Full Text] [Related]
40. High bone density in young Hutterite children. Wey CL, Beare T, Biskeborn K, Binkley T, Arneson L, Specker B. Bone; 2009 Mar; 44(3):454-60. PubMed ID: 19095089 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]